Ascendis Pharma A/S (ASND) reporting calendar
Ascendis Pharma A/S files periodic reports with the SEC as ASND on Nasdaq. Atlas tracks 12 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 11 Feb 2026
- Reports on record
- 12
Open ASND market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 11 Feb 2026 | 42 days | 0001193125-26-046590 |
| 20-F | 31 Dec 2024 | 12 Feb 2025 | 43 days | 0000950170-25-018852 |
| 20-F | 31 Dec 2023 | 7 Feb 2024 | 38 days | 0000950170-24-012212 |
| 20-F | 31 Dec 2022 | 16 Feb 2023 | 47 days | 0000950170-23-003068 |
| 20-F | 31 Dec 2021 | 2 Mar 2022 | 61 days | 0001193125-22-062998 |
| 20-F | 31 Dec 2020 | 10 Mar 2021 | 69 days | 0001193125-21-076349 |
| 20-F | 31 Dec 2019 | 3 Apr 2020 | 94 days | 0001193125-20-096870 |
| 20-F | 31 Dec 2018 | 3 Apr 2019 | 93 days | 0001193125-19-096759 |
| 20-F | 31 Dec 2017 | 28 Mar 2018 | 87 days | 0001193125-18-099514 |
| 20-F | 31 Dec 2016 | 22 Mar 2017 | 81 days | 0001193125-17-092073 |
| 20-F | 31 Dec 2015 | 15 Apr 2016 | 106 days | 0001193125-16-543253 |
| 20-F | 31 Dec 2014 | 26 Mar 2015 | 85 days | 0001193125-15-107137 |
Source: SEC EDGAR company submissions for CIK 0001612042. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.